| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 86.51▼ | 86.51▼ | 86.51▼ | 87.01▼ | 85.80▲ |
| MA10 | 86.89▼ | 86.89▼ | 86.25▼ | 85.57▲ | 84.92▲ |
| MA20 | 85.74▲ | 85.89▲ | 85.64▲ | 85.25▲ | 84.52▲ |
| MA50 | 85.13▲ | 85.29▲ | 85.34▲ | 85.34▲ | 75.49▲ |
| MA100 | 86.98▼ | 86.80▼ | 86.54▼ | 83.97▲ | 67.70▲ |
| MA200 | 83.63▲ | 82.48▲ | 81.68▲ | 76.61▲ | 57.44▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.042▲ | 0.037▲ | 0.150▲ | 0.227▲ | -0.487▼ |
| RSI | 52.230▲ | 51.940▲ | 52.976▲ | 53.256▲ | 59.676▲ |
| STOCH | 47.956 | 47.956 | 64.307 | 76.554 | 59.666 |
| WILL %R | -43.039 | -43.039 | -32.948 | -35.441 | -39.165 |
| CCI | 0.330 | 0.330 | 33.522 | 13.612 | 12.012 |
|
Friday, December 26, 2025 07:09 AM
The Brazilian Patent Office (INPI) issued Patent No. BR112015002697-4, titled "Use of an A3 Adenosine Receptor Agonist for the Treatment of Sexual Dysfunction," strengthening Can-Fite’s intellectual ...
|
|
Friday, December 26, 2025 06:02 AM
Can-Fite is advancing its proprietary A3AR agonist platform across multiple indications, including oncology and inflammatory diseases. ・The new patent expands Can-Fite’s IP coverage in Brazil and ...
|
|
Friday, December 26, 2025 04:15 AM
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/12/25 | 86.14 | 86.31 | 86.0501 | 86.17 | 6,696 |
| 26/12/25 | 86.59 | 86.71 | 86.295 | 86.49 | 8,306 |
| 24/12/25 | 87.59 | 87.59 | 86.98 | 87.29 | 2,200 |
| 23/12/25 | 87.25 | 87.645 | 87.25 | 87.53 | 3,514 |
| 22/12/25 | 86.60 | 88.03 | 86.60 | 87.59 | 9,842 |
| 19/12/25 | 83.93 | 85.73 | 83.93 | 85.66 | 6,100 |
| 18/12/25 | 83.61 | 84.29 | 83.5644 | 83.5644 | 4,725 |
| 17/12/25 | 84.43 | 84.57 | 82.29 | 82.32 | 7,000 |
| 16/12/25 | 84.44 | 84.967 | 83.845 | 84.25 | 7,500 |
| 15/12/25 | 85.44 | 85.5224 | 84.78 | 84.8834 | 3,179 |
|
|
||||
|
|
||||
|
|